Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences (ATAI – Research Report), with ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
As the U.S. stock market navigates a week of fluctuating earnings reports and economic indicators, investors are keenly observing opportunities across various sectors. Penny stocks, often associated ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
These are some of the penny stocks with interesting charts using technical analysis that performed well over the past 30 days ...
(RTTNews) - Biopharmaceutical company atai Life Sciences N.V. (ATAI) announced Friday key leadership appointments to advance its goal of delivering novel mental health therapeutics. Srinivas Rao ...
Shares of companies developing psychedelic treatments jumped while those of vaccine makers slipped after a Senate committee advanced the nomination of Robert F. Kennedy Jr. to lead the Health and ...
NEW YORK and BERLIN, Jan. 10, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback